Table 3 Zygomatic implant survival dataset
From: Long-term treatment outcomes with zygomatic implants: a systematic review and meta-analysis
Study | Patient number | Zygomatic implant number | Number of failed implants | Number of patients failure in | Survival | Follow-up Mean (months) | Follow-up range (months) |
|---|---|---|---|---|---|---|---|
Kahnberg et al. 2007 | 76 | 145 | 5 (3.45%) | 4 (5.26%) | 96.5 | 36 | N/A |
Pellegrino et al. 2020 | 20 | 73 | 2 (2.75%) | 2 (10%) | 97.3 | 39.9 |  ± 19.5 |
Aparicio et al. 2014 | 80 | 157 | 5 (3.18%) | 2 (2.5%) | 96.8 | 55.4 |  ± 234.7 |
Coppede et al. 2017 | 42 | 94 | 1 (1.06%) | 1 (2.38%) | 98.9 | 60 | N/A |
Davo and Pons 2015 | 14 | 68 | 0 (0.00%) | 0 (0.00%) | 100 | 60 | N/A |
Malo et al. 2014 | 39 | 92 | 1 (1.09%) | 1 (2.56%) | 98.9 | 60 | N/A |
Davo, Malevez and Pons 2013 | 36 | 69 | 1 (1.45%) | 1 (2.78%) | 98.6 | 60 | N/A |
Davo 2009 | 21 | 39 | 1 (2.56%) | 1 (4.76%) | 97.4 | 60 | N/A |
Branemark et al. 2004 | 28 | 52 | 3 (5.77%) | 3 (10.71%) | 94.2 | 60 | 60–120 |
Yates et al. 2013 | 23 | 43 | 6 (13.95%) | 6 (26.09%) | 86.1 | 72 | 48–72 |
Bedrossian 2010 | 36 | 74 | 2 (2.70%) | 2 (5.56%) | 97.3 | 84 | − 84 |
Agliardi et al. 2017 | 15 | 42 | 0 (0.00%) | 0 (0.00%) | 100 | 85 | 73–91 |
Chana et al. 2019 | 45 | 88 | 5 (5.69%) | 3 (6.66%) | 94.3 | 90 | Not reported |
Miglioranca et al. 2012 | 21 | 40 | 1 (2.50%) | 1 (4.76%) | 97.5 | 96 | Not reported |
Fortin 2017 | 58 | 107 | 0 (0.00%) | 0 (0.00%) | 100 | 101 | 60–156 |
Bothur et al. 2015 | 14 | 58 | 2 (3.45%) | 1 (7.14%) | 96.6 | 112 | 69.6–144 |
Aparicio et al. 2014 | 22 | 41 | 2 (4.88%) | 1 (4.55%) | 95.1 | 120 |  ± 154.1 |
Di Cosola et al. 2021 | 33 | 67 | 16 (23.88%) | 8 (24.24%) | 76.1 | 142 | 109–198 |